Pharming PHAR
NASDAQ PHAR
$9.65 -0.10 (-1.03%)
As of: Oct 21, 2026 · 2:25 PM EDT

Pharming (PHAR) Debt Ratio (2019 - 2024)

Updated

Pharming's Debt Ratio came in at 0.37 for Q3 2022.

Analysis

Pharming (PHAR) Debt Ratio (2019 - 2024) Analysis & Trends

For FY2020, Pharming's Debt Ratio was 0.06, down 81.6% from FY2019.

  • Going back by year, Debt Ratio was 0.30 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Pharming 664.67 Mn -129.70 Mn 141.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -0.01
Dec 31, 2023 0.00
Jun 30, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.37
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.46
Dec 31, 2020 0.06
Dec 31, 2019 0.30
API Access

Pharming Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=PHAR&period=max&api_key=YOUR_API_KEY